EUTECNIQ Sciences

See every page on one mapArrow keys move through results · Enter opens · Esc closes

Platform · Demonstration 3 · The consistency problem

A passing assay does not make a consistent ingredient

A published study measured 11 constituents and a chromatographic fingerprint in 51 batches of ginkgo tablets and capsules from 25 manufacturers. Of the 38 batches inside a marker range, 14 fail the authors' fingerprint threshold.

This page lets you set the specification, add tests one at a time and see which batches survive and how much of each constituent a serving would deliver.

Proposed capabilityCompany in formation (what exists today). Every value here is a published measurement by Liu et al. (2022); the specification, decision rules, serving size and blends are hypothetical.

Marker content against fingerprint similarity, 51 batches

Horizontal: sum of six flavonol glycosides, mg per 40 mg extract. Vertical: similarity of each batch's UPLC fingerprint to the common pattern (1.0 = identical).

Fifty-one ginkgo batches: marker content against fingerprint similarityMeasured data from Liu et al. 2022, Table 2: 51 batches of ginkgo tablets and capsules. Horizontal axis: sum of six flavonol glycosides, mg per 40 mg extract, from 4.12 to 8.89. Vertical axis: fingerprint similarity to the common pattern of the 51 batches, 0.45 to 1.00. 38 batches fall inside a hypothetical specification of 5.0 to 7.0 mg; 14 of them are below the authors' similarity cut of 0.85.Inside the range, similarity below 0.85 (n = 14)Other batches (n = 37)Hypothetical specification, 5.0–7.0 mgAuthors' similarity cut, 0.850.40.50.60.70.80.91.0456789Sum of six flavonol glycosides, mg per 40 mg extract (UPLC-DAD)Fingerprint similarity to the common pattern14 of 38 in rangefail the fingerprintV1L2A1: 6.252 mg, similarity 1.00B1: 6.303 mg, similarity 0.93C1: 7.324 mg, similarity 0.89D1: 5.097 mg, similarity 0.90E1: 5.554 mg, similarity 0.86F1: 6.698 mg, similarity 0.86F2: 6.213 mg, similarity 0.87G1: 4.816 mg, similarity 0.92G2: 5.355 mg, similarity 0.86G3: 5.220 mg, similarity 0.86G4: 5.727 mg, similarity 0.91H1: 5.858 mg, similarity 0.86I1: 6.111 mg, similarity 0.98J1: 6.157 mg, similarity 0.93K1: 4.893 mg, similarity 0.75K2: 4.911 mg, similarity 0.86K5: 5.045 mg, similarity 0.85L2: 4.117 mg, similarity 0.71N2: 5.473 mg, similarity 0.87O1: 4.954 mg, similarity 0.78P1: 6.711 mg, similarity 0.88Q1: 5.013 mg, similarity 0.90Q2: 6.260 mg, similarity 0.92Q3: 5.846 mg, similarity 0.86R1: 4.959 mg, similarity 0.83S1: 8.886 mg, similarity 0.96S2: 7.427 mg, similarity 0.93V1: 8.895 mg, similarity 0.45V2: 4.437 mg, similarity 0.86W2: 6.409 mg, similarity 0.86W3: 5.506 mg, similarity 0.88X2: 6.302 mg, similarity 0.92X3: 6.757 mg, similarity 0.95X4: 5.889 mg, similarity 0.85X5: 8.136 mg, similarity 0.93X6: 8.621 mg, similarity 0.95X7: 6.128 mg, similarity 0.95K3: 5.782 mg, similarity 0.74K4: 5.951 mg, similarity 0.73L1: 5.992 mg, similarity 0.83M1: 6.966 mg, similarity 0.82N1: 5.743 mg, similarity 0.84R2: 5.449 mg, similarity 0.73R3: 6.139 mg, similarity 0.74T1: 5.202 mg, similarity 0.71U1: 6.214 mg, similarity 0.78V3: 5.187 mg, similarity 0.84W1: 6.019 mg, similarity 0.78X1: 5.977 mg, similarity 0.83Y1: 5.584 mg, similarity 0.73Y2: 5.098 mg, similarity 0.53Fifty-one ginkgo batches: marker content against fingerprint similarityMeasured data from Liu et al. 2022, Table 2: 51 batches of ginkgo tablets and capsules. Horizontal axis: sum of six flavonol glycosides, mg per 40 mg extract, from 4.12 to 8.89. Vertical axis: fingerprint similarity to the common pattern of the 51 batches, 0.45 to 1.00. 38 batches fall inside a hypothetical specification of 5.0 to 7.0 mg; 14 of them are below the authors' similarity cut of 0.85.Inside the range, similarity below 0.85 (n = 14)Other batches (n = 37)Hypothetical specification, 5.0–7.0 mgAuthors' similarity cut, 0.850.40.50.60.70.80.91.0456789Six flavonol glycosides, mg per 40 mg extractFingerprint similarity14 of 38 in rangefail the fingerprintV1L2A1: 6.252 mg, similarity 1.00B1: 6.303 mg, similarity 0.93C1: 7.324 mg, similarity 0.89D1: 5.097 mg, similarity 0.90E1: 5.554 mg, similarity 0.86F1: 6.698 mg, similarity 0.86F2: 6.213 mg, similarity 0.87G1: 4.816 mg, similarity 0.92G2: 5.355 mg, similarity 0.86G3: 5.220 mg, similarity 0.86G4: 5.727 mg, similarity 0.91H1: 5.858 mg, similarity 0.86I1: 6.111 mg, similarity 0.98J1: 6.157 mg, similarity 0.93K1: 4.893 mg, similarity 0.75K2: 4.911 mg, similarity 0.86K5: 5.045 mg, similarity 0.85L2: 4.117 mg, similarity 0.71N2: 5.473 mg, similarity 0.87O1: 4.954 mg, similarity 0.78P1: 6.711 mg, similarity 0.88Q1: 5.013 mg, similarity 0.90Q2: 6.260 mg, similarity 0.92Q3: 5.846 mg, similarity 0.86R1: 4.959 mg, similarity 0.83S1: 8.886 mg, similarity 0.96S2: 7.427 mg, similarity 0.93V1: 8.895 mg, similarity 0.45V2: 4.437 mg, similarity 0.86W2: 6.409 mg, similarity 0.86W3: 5.506 mg, similarity 0.88X2: 6.302 mg, similarity 0.92X3: 6.757 mg, similarity 0.95X4: 5.889 mg, similarity 0.85X5: 8.136 mg, similarity 0.93X6: 8.621 mg, similarity 0.95X7: 6.128 mg, similarity 0.95K3: 5.782 mg, similarity 0.74K4: 5.951 mg, similarity 0.73L1: 5.992 mg, similarity 0.83M1: 6.966 mg, similarity 0.82N1: 5.743 mg, similarity 0.84R2: 5.449 mg, similarity 0.73R3: 6.139 mg, similarity 0.74T1: 5.202 mg, similarity 0.71U1: 6.214 mg, similarity 0.78V3: 5.187 mg, similarity 0.84W1: 6.019 mg, similarity 0.78X1: 5.977 mg, similarity 0.83Y1: 5.584 mg, similarity 0.73Y2: 5.098 mg, similarity 0.53
Measured data Liu et al., Chin Med 2022;17:72, Table 2. The 5.0–7.0 mg range is a hypothetical specification; 0.85 is the authors' cut for low similarity. Not EUTECNIQ data. Every value is listed in section 02.

In brief · Outcomes

Of 51 batches, 38 pass the marker assay and 3 pass every check; each failure opens an investigation, not a finding of adulteration

The checks below are applied in order at the default settings: a hypothetical specification of 5.0–7.0 mg six-glycoside sum per 40 mg extract, then the further tests one at a time. The statistics and the data behind each count follow in sections 02 and 03.

Outcome of each check on the 51 published batches: batches failing it on its own, and batches still accepted once it is added in order
Check, in the order appliedFails this check on its ownStill accepted after adding it
Targeted assay, six-glycoside sum within 5.0–7.0 mg13 of 5138 of 51
Free quercetin at most 0.2 mg1 (L2, 0.272 mg), already outside the range38
Rutin at most 25% of the six glycosides12, including A1 at similarity 1.0030 (8 removed)
Fingerprint similarity at or above 0.8519; 14 of them inside the marker range18 (12 more removed)
Supplier qualificationOf the 12 manufacturers with several batches, only G has no batch failing an authenticity check (quercetin, rutin ratio or fingerprint)3, all from G; 6 held for lack of history; 42 rejected

What would trigger an investigation

  • Any failed check. A failed check marks a batch for investigation; it does not prove adulteration.
  • A break in a source's own pattern. Within manufacturer K, batches K3 and K4 contain 2.2 times the rutin of K1, K2 and K5 while the other five glycosides differ by at most 16%: a pattern worth an investigation, not a finding.
  • A source with one batch on record. Its batch is held, not accepted, until the source has a history.
  • The disposition that follows. Under Part 111 a component that fails its identity specification must be rejected (21 CFR 111.77(b)); other failures may be corrected only by a treatment, adjustment or reprocessing that quality control approves after a material review (111.77(a), 111.90). EUTECNIQ proposes to write the fingerprint and authenticity checks into identity. Proposed capability

Measured data Hypothetical example Counts computed from Liu et al. 2022, Table 2. The marker range, the 25% rutin limit and the supplier rule are hypothetical; the 0.2 mg quercetin limit and the 0.85 similarity cut are as stated by the authors. Table 3 of the paper lists 17 batches below 0.85, Table 2 gives 19, and this page uses Table 2 (section 02). Change any setting in section 03; each test's limits are in section 06.

01 · What a specification can see

Marker, class, fingerprint and activity are four different measurements

A botanical extract contains hundreds of compounds and a specification tests a few of them. Each kind of test answers its own question, and a pass on one says little about the others.

Marker concentration

How much of one named compound

A targeted assay quantifies one compound against its reference standard, such as rutin in mg per 40 mg extract. Compounds nobody looked for stay invisible.

Class or surrogate assay

One number for a group

The compendial ginkgo assay hydrolyzes flavonol glycosides and measures the released aglycones, so added aglycones or cheap glycosides raise the result. The six-glycoside sum used here adds six intact glycosides and is a different number.

Fingerprint

Does the whole pattern match a reference

Liu et al. compared 59 common chromatographic peaks with the common pattern of their own 51 batches. High similarity means close to this market, which is not the same as close to authenticated leaf extract.

Biological activity

What the material does

Activity needs a validated bioassay or a clinical study. No test in this dataset measures it, and a consistent marker shows consistent chemistry for that marker only.

A marker is not automatically the active. The European Medicines Agency separates active markers, “generally accepted to contribute to the therapeutic activity,” from analytical markers, which “serve solely for analytical purposes.” Published evidence

EMA/HMPC, Reflection paper on markers, EMEA/HMPC/253629/2007 (2008); Liu et al., Chin Med 2022 (introduction and methods); EMA/HMPC/321095/2012 (Ph. Eur. ginkgo extract specification, summarized in section 02). Next: the 51 profiles.

02 · The published data

Fifty-one batches, 25 manufacturers, 11 measured constituents

The flavonol glycosides vary least between batches. Organic acids, which no ginkgo specification on this page limits, vary up to 141-fold, and a few batches have profiles unlike the rest.

The 51 profiles: each constituent relative to the 51-batch mean

Rows: organic acids, flavonol glycosides and free quercetin. Columns: batches grouped by manufacturer. Warm shades: below the mean; cool shades: above.

The 51 batch profiles: each constituent relative to the 51-batch meanMeasured data from Liu et al. 2022, Table 2. Each cell is one constituent in one batch, shaded by its content relative to the mean of the 51 batches: warm (copper) shades below the mean, cool (steel) shades above, from a quarter or less to four times or more. Organic acids vary most: protocatechuic acid ranges from 0.008 to 1.132 mg per 40 mg extract. The six flavonol glycosides vary least, except in batch V2, where two coumaroyl glycosides and QDG are far below the mean. Free quercetin is highest in L2. Every value is in the data table below the figure.ABCDEFGHIJKLMNOPQRSTUVWXY6-HKApHAGAPAKRKRCGQDGQCGRutinIRQuercetinA1, 6-HKA: 0.048 mg per 40 mg (2.19× mean)A1, pHA: 0.033 mg per 40 mg (1.00× mean)A1, GA: 0.014 mg per 40 mg (1.18× mean)A1, PA: 0.365 mg per 40 mg (1.46× mean)A1, KR: 0.818 mg per 40 mg (0.99× mean)A1, KRCG: 0.820 mg per 40 mg (0.80× mean)A1, QDG: 1.009 mg per 40 mg (1.07× mean)A1, QCG: 0.886 mg per 40 mg (0.71× mean)A1, Rutin: 2.075 mg per 40 mg (1.77× mean)A1, IR: 0.644 mg per 40 mg (0.82× mean)A1, Quercetin: 0.038 mg per 40 mg (0.67× mean)B1, 6-HKA: 0.077 mg per 40 mg (3.52× mean)B1, pHA: 0.051 mg per 40 mg (1.55× mean)B1, GA: 0.053 mg per 40 mg (4.46× mean)B1, PA: 0.715 mg per 40 mg (2.86× mean)B1, KR: 0.814 mg per 40 mg (0.99× mean)B1, KRCG: 0.786 mg per 40 mg (0.77× mean)B1, QDG: 1.070 mg per 40 mg (1.14× mean)B1, QCG: 0.885 mg per 40 mg (0.71× mean)B1, Rutin: 2.116 mg per 40 mg (1.81× mean)B1, IR: 0.632 mg per 40 mg (0.81× mean)B1, Quercetin: 0.101 mg per 40 mg (1.78× mean)C1, 6-HKA: 0.007 mg per 40 mg (0.32× mean)C1, pHA: 0.016 mg per 40 mg (0.49× mean)C1, GA: 0.003 mg per 40 mg (0.25× mean)C1, PA: 0.070 mg per 40 mg (0.28× mean)C1, KR: 0.924 mg per 40 mg (1.12× mean)C1, KRCG: 1.040 mg per 40 mg (1.02× mean)C1, QDG: 1.080 mg per 40 mg (1.15× mean)C1, QCG: 1.240 mg per 40 mg (0.99× mean)C1, Rutin: 2.196 mg per 40 mg (1.87× mean)C1, IR: 0.844 mg per 40 mg (1.08× mean)C1, Quercetin: 0.091 mg per 40 mg (1.60× mean)D1, 6-HKA: 0.020 mg per 40 mg (0.91× mean)D1, pHA: 0.025 mg per 40 mg (0.76× mean)D1, GA: 0.005 mg per 40 mg (0.42× mean)D1, PA: 0.141 mg per 40 mg (0.56× mean)D1, KR: 0.756 mg per 40 mg (0.92× mean)D1, KRCG: 0.947 mg per 40 mg (0.93× mean)D1, QDG: 0.675 mg per 40 mg (0.72× mean)D1, QCG: 1.194 mg per 40 mg (0.95× mean)D1, Rutin: 0.774 mg per 40 mg (0.66× mean)D1, IR: 0.751 mg per 40 mg (0.96× mean)D1, Quercetin: 0.056 mg per 40 mg (0.99× mean)E1, 6-HKA: 0.010 mg per 40 mg (0.46× mean)E1, pHA: 0.037 mg per 40 mg (1.12× mean)E1, GA: not detectedE1, PA: 0.090 mg per 40 mg (0.36× mean)E1, KR: 0.724 mg per 40 mg (0.88× mean)E1, KRCG: 1.193 mg per 40 mg (1.17× mean)E1, QDG: 0.990 mg per 40 mg (1.05× mean)E1, QCG: 1.311 mg per 40 mg (1.05× mean)E1, Rutin: 0.773 mg per 40 mg (0.66× mean)E1, IR: 0.563 mg per 40 mg (0.72× mean)E1, Quercetin: 0.045 mg per 40 mg (0.79× mean)F1, 6-HKA: 0.022 mg per 40 mg (1.01× mean)F1, pHA: 0.061 mg per 40 mg (1.85× mean)F1, GA: 0.065 mg per 40 mg (5.47× mean)F1, PA: 0.908 mg per 40 mg (3.63× mean)F1, KR: 0.831 mg per 40 mg (1.01× mean)F1, KRCG: 0.913 mg per 40 mg (0.90× mean)F1, QDG: 1.117 mg per 40 mg (1.19× mean)F1, QCG: 1.111 mg per 40 mg (0.89× mean)F1, Rutin: 1.964 mg per 40 mg (1.68× mean)F1, IR: 0.762 mg per 40 mg (0.97× mean)F1, Quercetin: 0.023 mg per 40 mg (0.41× mean)F2, 6-HKA: 0.007 mg per 40 mg (0.32× mean)F2, pHA: 0.065 mg per 40 mg (1.97× mean)F2, GA: 0.049 mg per 40 mg (4.12× mean)F2, PA: 0.955 mg per 40 mg (3.82× mean)F2, KR: 0.897 mg per 40 mg (1.09× mean)F2, KRCG: 1.007 mg per 40 mg (0.99× mean)F2, QDG: 1.188 mg per 40 mg (1.26× mean)F2, QCG: 1.215 mg per 40 mg (0.97× mean)F2, Rutin: 1.071 mg per 40 mg (0.91× mean)F2, IR: 0.835 mg per 40 mg (1.07× mean)F2, Quercetin: 0.027 mg per 40 mg (0.48× mean)G1, 6-HKA: 0.007 mg per 40 mg (0.32× mean)G1, pHA: 0.026 mg per 40 mg (0.79× mean)G1, GA: not detectedG1, PA: 0.213 mg per 40 mg (0.85× mean)G1, KR: 0.791 mg per 40 mg (0.96× mean)G1, KRCG: 0.692 mg per 40 mg (0.68× mean)G1, QDG: 0.886 mg per 40 mg (0.94× mean)G1, QCG: 0.856 mg per 40 mg (0.68× mean)G1, Rutin: 0.805 mg per 40 mg (0.69× mean)G1, IR: 0.786 mg per 40 mg (1.00× mean)G1, Quercetin: 0.018 mg per 40 mg (0.32× mean)G2, 6-HKA: 0.006 mg per 40 mg (0.27× mean)G2, pHA: 0.035 mg per 40 mg (1.06× mean)G2, GA: not detectedG2, PA: 0.183 mg per 40 mg (0.73× mean)G2, KR: 0.858 mg per 40 mg (1.04× mean)G2, KRCG: 0.815 mg per 40 mg (0.80× mean)G2, QDG: 0.864 mg per 40 mg (0.92× mean)G2, QCG: 1.135 mg per 40 mg (0.91× mean)G2, Rutin: 0.887 mg per 40 mg (0.76× mean)G2, IR: 0.796 mg per 40 mg (1.02× mean)G2, Quercetin: 0.020 mg per 40 mg (0.35× mean)G3, 6-HKA: 0.008 mg per 40 mg (0.37× mean)G3, pHA: 0.031 mg per 40 mg (0.94× mean)G3, GA: not detectedG3, PA: 0.187 mg per 40 mg (0.75× mean)G3, KR: 0.803 mg per 40 mg (0.98× mean)G3, KRCG: 0.803 mg per 40 mg (0.79× mean)G3, QDG: 0.885 mg per 40 mg (0.94× mean)G3, QCG: 1.119 mg per 40 mg (0.89× mean)G3, Rutin: 0.869 mg per 40 mg (0.74× mean)G3, IR: 0.741 mg per 40 mg (0.95× mean)G3, Quercetin: 0.024 mg per 40 mg (0.42× mean)G4, 6-HKA: 0.004 mg per 40 mg (0.18× mean)G4, pHA: 0.037 mg per 40 mg (1.12× mean)G4, GA: not detectedG4, PA: 0.215 mg per 40 mg (0.86× mean)G4, KR: 0.878 mg per 40 mg (1.07× mean)G4, KRCG: 0.893 mg per 40 mg (0.88× mean)G4, QDG: 1.019 mg per 40 mg (1.08× mean)G4, QCG: 1.204 mg per 40 mg (0.96× mean)G4, Rutin: 0.915 mg per 40 mg (0.78× mean)G4, IR: 0.818 mg per 40 mg (1.05× mean)G4, Quercetin: 0.026 mg per 40 mg (0.46× mean)H1, 6-HKA: 0.007 mg per 40 mg (0.32× mean)H1, pHA: 0.026 mg per 40 mg (0.79× mean)H1, GA: not detectedH1, PA: 0.068 mg per 40 mg (0.27× mean)H1, KR: 0.744 mg per 40 mg (0.90× mean)H1, KRCG: 1.101 mg per 40 mg (1.08× mean)H1, QDG: 1.116 mg per 40 mg (1.19× mean)H1, QCG: 1.384 mg per 40 mg (1.10× mean)H1, Rutin: 0.809 mg per 40 mg (0.69× mean)H1, IR: 0.704 mg per 40 mg (0.90× mean)H1, Quercetin: 0.038 mg per 40 mg (0.67× mean)I1, 6-HKA: 0.057 mg per 40 mg (2.60× mean)I1, pHA: 0.027 mg per 40 mg (0.82× mean)I1, GA: 0.019 mg per 40 mg (1.60× mean)I1, PA: 0.421 mg per 40 mg (1.68× mean)I1, KR: 0.960 mg per 40 mg (1.17× mean)I1, KRCG: 0.989 mg per 40 mg (0.97× mean)I1, QDG: 0.892 mg per 40 mg (0.95× mean)I1, QCG: 1.240 mg per 40 mg (0.99× mean)I1, Rutin: 1.144 mg per 40 mg (0.98× mean)I1, IR: 0.886 mg per 40 mg (1.13× mean)I1, Quercetin: 0.022 mg per 40 mg (0.39× mean)J1, 6-HKA: 0.029 mg per 40 mg (1.33× mean)J1, pHA: 0.074 mg per 40 mg (2.25× mean)J1, GA: 0.047 mg per 40 mg (3.96× mean)J1, PA: 0.692 mg per 40 mg (2.77× mean)J1, KR: 0.925 mg per 40 mg (1.12× mean)J1, KRCG: 1.042 mg per 40 mg (1.02× mean)J1, QDG: 1.206 mg per 40 mg (1.28× mean)J1, QCG: 1.292 mg per 40 mg (1.03× mean)J1, Rutin: 0.859 mg per 40 mg (0.73× mean)J1, IR: 0.833 mg per 40 mg (1.06× mean)J1, Quercetin: 0.022 mg per 40 mg (0.39× mean)K1, 6-HKA: 0.018 mg per 40 mg (0.82× mean)K1, pHA: 0.032 mg per 40 mg (0.97× mean)K1, GA: not detectedK1, PA: 0.056 mg per 40 mg (0.22× mean)K1, KR: 0.598 mg per 40 mg (0.73× mean)K1, KRCG: 1.026 mg per 40 mg (1.01× mean)K1, QDG: 0.842 mg per 40 mg (0.89× mean)K1, QCG: 1.227 mg per 40 mg (0.98× mean)K1, Rutin: 0.693 mg per 40 mg (0.59× mean)K1, IR: 0.507 mg per 40 mg (0.65× mean)K1, Quercetin: 0.056 mg per 40 mg (0.99× mean)K2, 6-HKA: 0.018 mg per 40 mg (0.82× mean)K2, pHA: 0.035 mg per 40 mg (1.06× mean)K2, GA: not detectedK2, PA: 0.062 mg per 40 mg (0.25× mean)K2, KR: 0.627 mg per 40 mg (0.76× mean)K2, KRCG: 1.011 mg per 40 mg (0.99× mean)K2, QDG: 0.831 mg per 40 mg (0.88× mean)K2, QCG: 1.206 mg per 40 mg (0.96× mean)K2, Rutin: 0.700 mg per 40 mg (0.60× mean)K2, IR: 0.536 mg per 40 mg (0.68× mean)K2, Quercetin: 0.052 mg per 40 mg (0.92× mean)K3, 6-HKA: 0.020 mg per 40 mg (0.91× mean)K3, pHA: 0.034 mg per 40 mg (1.03× mean)K3, GA: 0.009 mg per 40 mg (0.76× mean)K3, PA: 0.066 mg per 40 mg (0.26× mean)K3, KR: 0.612 mg per 40 mg (0.74× mean)K3, KRCG: 0.970 mg per 40 mg (0.95× mean)K3, QDG: 0.908 mg per 40 mg (0.96× mean)K3, QCG: 1.135 mg per 40 mg (0.91× mean)K3, Rutin: 1.636 mg per 40 mg (1.40× mean)K3, IR: 0.521 mg per 40 mg (0.67× mean)K3, Quercetin: 0.052 mg per 40 mg (0.92× mean)K4, 6-HKA: 0.019 mg per 40 mg (0.87× mean)K4, pHA: 0.034 mg per 40 mg (1.03× mean)K4, GA: not detectedK4, PA: 0.032 mg per 40 mg (0.13× mean)K4, KR: 0.613 mg per 40 mg (0.74× mean)K4, KRCG: 1.003 mg per 40 mg (0.98× mean)K4, QDG: 0.961 mg per 40 mg (1.02× mean)K4, QCG: 1.173 mg per 40 mg (0.94× mean)K4, Rutin: 1.675 mg per 40 mg (1.43× mean)K4, IR: 0.526 mg per 40 mg (0.67× mean)K4, Quercetin: 0.048 mg per 40 mg (0.85× mean)K5, 6-HKA: 0.018 mg per 40 mg (0.82× mean)K5, pHA: 0.028 mg per 40 mg (0.85× mean)K5, GA: not detectedK5, PA: 0.058 mg per 40 mg (0.23× mean)K5, KR: 0.597 mg per 40 mg (0.72× mean)K5, KRCG: 1.002 mg per 40 mg (0.98× mean)K5, QDG: 0.932 mg per 40 mg (0.99× mean)K5, QCG: 1.170 mg per 40 mg (0.93× mean)K5, Rutin: 0.833 mg per 40 mg (0.71× mean)K5, IR: 0.511 mg per 40 mg (0.65× mean)K5, Quercetin: 0.078 mg per 40 mg (1.38× mean)L1, 6-HKA: 0.009 mg per 40 mg (0.41× mean)L1, pHA: 0.079 mg per 40 mg (2.40× mean)L1, GA: 0.054 mg per 40 mg (4.54× mean)L1, PA: 1.132 mg per 40 mg (4.52× mean)L1, KR: 0.880 mg per 40 mg (1.07× mean)L1, KRCG: 1.026 mg per 40 mg (1.01× mean)L1, QDG: 1.127 mg per 40 mg (1.20× mean)L1, QCG: 1.301 mg per 40 mg (1.04× mean)L1, Rutin: 0.823 mg per 40 mg (0.70× mean)L1, IR: 0.835 mg per 40 mg (1.07× mean)L1, Quercetin: 0.021 mg per 40 mg (0.37× mean)L2, 6-HKA: 0.005 mg per 40 mg (0.23× mean)L2, pHA: 0.030 mg per 40 mg (0.91× mean)L2, GA: not detectedL2, PA: 0.100 mg per 40 mg (0.40× mean)L2, KR: 0.491 mg per 40 mg (0.60× mean)L2, KRCG: 0.898 mg per 40 mg (0.88× mean)L2, QDG: 0.614 mg per 40 mg (0.65× mean)L2, QCG: 1.121 mg per 40 mg (0.89× mean)L2, Rutin: 0.501 mg per 40 mg (0.43× mean)L2, IR: 0.492 mg per 40 mg (0.63× mean)L2, Quercetin: 0.272 mg per 40 mg (4.80× mean)M1, 6-HKA: 0.009 mg per 40 mg (0.41× mean)M1, pHA: 0.022 mg per 40 mg (0.67× mean)M1, GA: not detectedM1, PA: 0.105 mg per 40 mg (0.42× mean)M1, KR: 1.011 mg per 40 mg (1.23× mean)M1, KRCG: 1.324 mg per 40 mg (1.30× mean)M1, QDG: 1.152 mg per 40 mg (1.22× mean)M1, QCG: 1.559 mg per 40 mg (1.24× mean)M1, Rutin: 0.973 mg per 40 mg (0.83× mean)M1, IR: 0.947 mg per 40 mg (1.21× mean)M1, Quercetin: 0.048 mg per 40 mg (0.85× mean)N1, 6-HKA: 0.011 mg per 40 mg (0.50× mean)N1, pHA: 0.025 mg per 40 mg (0.76× mean)N1, GA: 0.001 mg per 40 mg (0.08× mean)N1, PA: 0.055 mg per 40 mg (0.22× mean)N1, KR: 0.797 mg per 40 mg (0.97× mean)N1, KRCG: 1.105 mg per 40 mg (1.08× mean)N1, QDG: 1.010 mg per 40 mg (1.07× mean)N1, QCG: 1.308 mg per 40 mg (1.04× mean)N1, Rutin: 0.797 mg per 40 mg (0.68× mean)N1, IR: 0.726 mg per 40 mg (0.93× mean)N1, Quercetin: 0.060 mg per 40 mg (1.06× mean)N2, 6-HKA: 0.014 mg per 40 mg (0.64× mean)N2, pHA: 0.027 mg per 40 mg (0.82× mean)N2, GA: not detectedN2, PA: 0.067 mg per 40 mg (0.27× mean)N2, KR: 0.808 mg per 40 mg (0.98× mean)N2, KRCG: 1.071 mg per 40 mg (1.05× mean)N2, QDG: 0.829 mg per 40 mg (0.88× mean)N2, QCG: 1.240 mg per 40 mg (0.99× mean)N2, Rutin: 0.790 mg per 40 mg (0.67× mean)N2, IR: 0.735 mg per 40 mg (0.94× mean)N2, Quercetin: 0.053 mg per 40 mg (0.93× mean)O1, 6-HKA: not detectedO1, pHA: 0.009 mg per 40 mg (0.27× mean)O1, GA: not detectedO1, PA: 0.008 mg per 40 mg (0.03× mean)O1, KR: 0.706 mg per 40 mg (0.86× mean)O1, KRCG: 1.098 mg per 40 mg (1.08× mean)O1, QDG: 0.339 mg per 40 mg (0.36× mean)O1, QCG: 1.373 mg per 40 mg (1.10× mean)O1, Rutin: 0.820 mg per 40 mg (0.70× mean)O1, IR: 0.618 mg per 40 mg (0.79× mean)O1, Quercetin: 0.075 mg per 40 mg (1.32× mean)P1, 6-HKA: 0.016 mg per 40 mg (0.73× mean)P1, pHA: 0.034 mg per 40 mg (1.03× mean)P1, GA: 0.002 mg per 40 mg (0.17× mean)P1, PA: 0.200 mg per 40 mg (0.80× mean)P1, KR: 1.108 mg per 40 mg (1.35× mean)P1, KRCG: 1.034 mg per 40 mg (1.01× mean)P1, QDG: 1.056 mg per 40 mg (1.12× mean)P1, QCG: 1.124 mg per 40 mg (0.90× mean)P1, Rutin: 1.207 mg per 40 mg (1.03× mean)P1, IR: 1.182 mg per 40 mg (1.51× mean)P1, Quercetin: 0.072 mg per 40 mg (1.27× mean)Q1, 6-HKA: 0.009 mg per 40 mg (0.41× mean)Q1, pHA: 0.039 mg per 40 mg (1.18× mean)Q1, GA: 0.002 mg per 40 mg (0.17× mean)Q1, PA: 0.142 mg per 40 mg (0.57× mean)Q1, KR: 0.859 mg per 40 mg (1.04× mean)Q1, KRCG: 0.875 mg per 40 mg (0.86× mean)Q1, QDG: 0.650 mg per 40 mg (0.69× mean)Q1, QCG: 1.112 mg per 40 mg (0.89× mean)Q1, Rutin: 0.800 mg per 40 mg (0.68× mean)Q1, IR: 0.717 mg per 40 mg (0.92× mean)Q1, Quercetin: 0.030 mg per 40 mg (0.53× mean)Q2, 6-HKA: 0.023 mg per 40 mg (1.05× mean)Q2, pHA: 0.038 mg per 40 mg (1.15× mean)Q2, GA: 0.010 mg per 40 mg (0.84× mean)Q2, PA: 0.195 mg per 40 mg (0.78× mean)Q2, KR: 0.708 mg per 40 mg (0.86× mean)Q2, KRCG: 0.932 mg per 40 mg (0.91× mean)Q2, QDG: 0.910 mg per 40 mg (0.97× mean)Q2, QCG: 1.244 mg per 40 mg (0.99× mean)Q2, Rutin: 1.873 mg per 40 mg (1.60× mean)Q2, IR: 0.593 mg per 40 mg (0.76× mean)Q2, Quercetin: 0.018 mg per 40 mg (0.32× mean)Q3, 6-HKA: 0.004 mg per 40 mg (0.18× mean)Q3, pHA: 0.035 mg per 40 mg (1.06× mean)Q3, GA: 0.005 mg per 40 mg (0.42× mean)Q3, PA: 0.112 mg per 40 mg (0.45× mean)Q3, KR: 0.773 mg per 40 mg (0.94× mean)Q3, KRCG: 0.840 mg per 40 mg (0.82× mean)Q3, QDG: 0.735 mg per 40 mg (0.78× mean)Q3, QCG: 1.119 mg per 40 mg (0.89× mean)Q3, Rutin: 1.725 mg per 40 mg (1.47× mean)Q3, IR: 0.654 mg per 40 mg (0.84× mean)Q3, Quercetin: 0.042 mg per 40 mg (0.74× mean)R1, 6-HKA: 0.002 mg per 40 mg (0.09× mean)R1, pHA: 0.023 mg per 40 mg (0.70× mean)R1, GA: not detectedR1, PA: 0.039 mg per 40 mg (0.16× mean)R1, KR: 0.696 mg per 40 mg (0.85× mean)R1, KRCG: 0.982 mg per 40 mg (0.96× mean)R1, QDG: 0.805 mg per 40 mg (0.86× mean)R1, QCG: 1.160 mg per 40 mg (0.93× mean)R1, Rutin: 0.615 mg per 40 mg (0.52× mean)R1, IR: 0.701 mg per 40 mg (0.90× mean)R1, Quercetin: 0.142 mg per 40 mg (2.50× mean)R2, 6-HKA: 0.008 mg per 40 mg (0.37× mean)R2, pHA: 0.029 mg per 40 mg (0.88× mean)R2, GA: not detectedR2, PA: 0.037 mg per 40 mg (0.15× mean)R2, KR: 0.752 mg per 40 mg (0.91× mean)R2, KRCG: 1.071 mg per 40 mg (1.05× mean)R2, QDG: 0.943 mg per 40 mg (1.00× mean)R2, QCG: 1.256 mg per 40 mg (1.00× mean)R2, Rutin: 0.669 mg per 40 mg (0.57× mean)R2, IR: 0.758 mg per 40 mg (0.97× mean)R2, Quercetin: 0.148 mg per 40 mg (2.61× mean)R3, 6-HKA: 0.009 mg per 40 mg (0.41× mean)R3, pHA: 0.029 mg per 40 mg (0.88× mean)R3, GA: not detectedR3, PA: 0.038 mg per 40 mg (0.15× mean)R3, KR: 0.761 mg per 40 mg (0.92× mean)R3, KRCG: 1.075 mg per 40 mg (1.05× mean)R3, QDG: 0.925 mg per 40 mg (0.98× mean)R3, QCG: 1.248 mg per 40 mg (1.00× mean)R3, Rutin: 1.358 mg per 40 mg (1.16× mean)R3, IR: 0.772 mg per 40 mg (0.99× mean)R3, Quercetin: 0.155 mg per 40 mg (2.73× mean)S1, 6-HKA: 0.034 mg per 40 mg (1.55× mean)S1, pHA: 0.050 mg per 40 mg (1.52× mean)S1, GA: 0.030 mg per 40 mg (2.52× mean)S1, PA: 0.697 mg per 40 mg (2.79× mean)S1, KR: 1.296 mg per 40 mg (1.57× mean)S1, KRCG: 1.160 mg per 40 mg (1.14× mean)S1, QDG: 0.935 mg per 40 mg (0.99× mean)S1, QCG: 1.404 mg per 40 mg (1.12× mean)S1, Rutin: 2.906 mg per 40 mg (2.48× mean)S1, IR: 1.185 mg per 40 mg (1.51× mean)S1, Quercetin: 0.029 mg per 40 mg (0.51× mean)S2, 6-HKA: 0.058 mg per 40 mg (2.65× mean)S2, pHA: 0.045 mg per 40 mg (1.37× mean)S2, GA: 0.024 mg per 40 mg (2.02× mean)S2, PA: 0.669 mg per 40 mg (2.67× mean)S2, KR: 1.333 mg per 40 mg (1.62× mean)S2, KRCG: 1.135 mg per 40 mg (1.11× mean)S2, QDG: 1.118 mg per 40 mg (1.19× mean)S2, QCG: 1.362 mg per 40 mg (1.09× mean)S2, Rutin: 1.247 mg per 40 mg (1.06× mean)S2, IR: 1.232 mg per 40 mg (1.57× mean)S2, Quercetin: 0.032 mg per 40 mg (0.56× mean)T1, 6-HKA: 0.002 mg per 40 mg (0.09× mean)T1, pHA: 0.027 mg per 40 mg (0.82× mean)T1, GA: not detectedT1, PA: 0.063 mg per 40 mg (0.25× mean)T1, KR: 0.700 mg per 40 mg (0.85× mean)T1, KRCG: 1.053 mg per 40 mg (1.03× mean)T1, QDG: 0.904 mg per 40 mg (0.96× mean)T1, QCG: 1.207 mg per 40 mg (0.96× mean)T1, Rutin: 0.630 mg per 40 mg (0.54× mean)T1, IR: 0.708 mg per 40 mg (0.90× mean)T1, Quercetin: 0.151 mg per 40 mg (2.66× mean)U1, 6-HKA: 0.003 mg per 40 mg (0.14× mean)U1, pHA: 0.015 mg per 40 mg (0.46× mean)U1, GA: not detectedU1, PA: 0.037 mg per 40 mg (0.15× mean)U1, KR: 0.935 mg per 40 mg (1.14× mean)U1, KRCG: 1.224 mg per 40 mg (1.20× mean)U1, QDG: 0.904 mg per 40 mg (0.96× mean)U1, QCG: 1.419 mg per 40 mg (1.13× mean)U1, Rutin: 0.873 mg per 40 mg (0.75× mean)U1, IR: 0.859 mg per 40 mg (1.10× mean)U1, Quercetin: 0.127 mg per 40 mg (2.24× mean)V1, 6-HKA: 0.029 mg per 40 mg (1.33× mean)V1, pHA: 0.046 mg per 40 mg (1.40× mean)V1, GA: not detectedV1, PA: 0.049 mg per 40 mg (0.20× mean)V1, KR: 0.913 mg per 40 mg (1.11× mean)V1, KRCG: 1.496 mg per 40 mg (1.47× mean)V1, QDG: 1.440 mg per 40 mg (1.53× mean)V1, QCG: 1.749 mg per 40 mg (1.40× mean)V1, Rutin: 2.507 mg per 40 mg (2.14× mean)V1, IR: 0.790 mg per 40 mg (1.01× mean)V1, Quercetin: 0.082 mg per 40 mg (1.45× mean)V2, 6-HKA: 0.015 mg per 40 mg (0.69× mean)V2, pHA: 0.045 mg per 40 mg (1.37× mean)V2, GA: 0.052 mg per 40 mg (4.38× mean)V2, PA: 0.033 mg per 40 mg (0.13× mean)V2, KR: 0.783 mg per 40 mg (0.95× mean)V2, KRCG: 0.059 mg per 40 mg (0.06× mean)V2, QDG: 0.086 mg per 40 mg (0.09× mean)V2, QCG: 0.368 mg per 40 mg (0.29× mean)V2, Rutin: 1.314 mg per 40 mg (1.12× mean)V2, IR: 1.827 mg per 40 mg (2.33× mean)V2, Quercetin: 0.041 mg per 40 mg (0.72× mean)V3, 6-HKA: 0.005 mg per 40 mg (0.23× mean)V3, pHA: 0.023 mg per 40 mg (0.70× mean)V3, GA: not detectedV3, PA: 0.022 mg per 40 mg (0.09× mean)V3, KR: 0.818 mg per 40 mg (0.99× mean)V3, KRCG: 0.896 mg per 40 mg (0.88× mean)V3, QDG: 0.724 mg per 40 mg (0.77× mean)V3, QCG: 1.070 mg per 40 mg (0.85× mean)V3, Rutin: 0.920 mg per 40 mg (0.79× mean)V3, IR: 0.759 mg per 40 mg (0.97× mean)V3, Quercetin: 0.036 mg per 40 mg (0.63× mean)W1, 6-HKA: 0.004 mg per 40 mg (0.18× mean)W1, pHA: 0.012 mg per 40 mg (0.36× mean)W1, GA: not detectedW1, PA: 0.018 mg per 40 mg (0.07× mean)W1, KR: 0.947 mg per 40 mg (1.15× mean)W1, KRCG: 1.115 mg per 40 mg (1.09× mean)W1, QDG: 0.912 mg per 40 mg (0.97× mean)W1, QCG: 1.262 mg per 40 mg (1.01× mean)W1, Rutin: 0.877 mg per 40 mg (0.75× mean)W1, IR: 0.906 mg per 40 mg (1.16× mean)W1, Quercetin: 0.020 mg per 40 mg (0.35× mean)W2, 6-HKA: 0.003 mg per 40 mg (0.14× mean)W2, pHA: 0.013 mg per 40 mg (0.39× mean)W2, GA: not detectedW2, PA: 0.018 mg per 40 mg (0.07× mean)W2, KR: 0.961 mg per 40 mg (1.17× mean)W2, KRCG: 1.135 mg per 40 mg (1.11× mean)W2, QDG: 0.981 mg per 40 mg (1.04× mean)W2, QCG: 1.319 mg per 40 mg (1.05× mean)W2, Rutin: 1.090 mg per 40 mg (0.93× mean)W2, IR: 0.923 mg per 40 mg (1.18× mean)W2, Quercetin: 0.022 mg per 40 mg (0.39× mean)W3, 6-HKA: 0.012 mg per 40 mg (0.55× mean)W3, pHA: 0.019 mg per 40 mg (0.58× mean)W3, GA: 0.011 mg per 40 mg (0.93× mean)W3, PA: 0.059 mg per 40 mg (0.24× mean)W3, KR: 0.807 mg per 40 mg (0.98× mean)W3, KRCG: 1.019 mg per 40 mg (1.00× mean)W3, QDG: 0.734 mg per 40 mg (0.78× mean)W3, QCG: 1.172 mg per 40 mg (0.94× mean)W3, Rutin: 0.915 mg per 40 mg (0.78× mean)W3, IR: 0.859 mg per 40 mg (1.10× mean)W3, Quercetin: 0.095 mg per 40 mg (1.67× mean)X1, 6-HKA: 0.035 mg per 40 mg (1.60× mean)X1, pHA: 0.032 mg per 40 mg (0.97× mean)X1, GA: 0.020 mg per 40 mg (1.68× mean)X1, PA: 0.554 mg per 40 mg (2.21× mean)X1, KR: 0.809 mg per 40 mg (0.98× mean)X1, KRCG: 1.123 mg per 40 mg (1.10× mean)X1, QDG: 1.107 mg per 40 mg (1.18× mean)X1, QCG: 1.363 mg per 40 mg (1.09× mean)X1, Rutin: 0.819 mg per 40 mg (0.70× mean)X1, IR: 0.756 mg per 40 mg (0.97× mean)X1, Quercetin: 0.021 mg per 40 mg (0.37× mean)X2, 6-HKA: 0.064 mg per 40 mg (2.92× mean)X2, pHA: 0.027 mg per 40 mg (0.82× mean)X2, GA: 0.019 mg per 40 mg (1.60× mean)X2, PA: 0.439 mg per 40 mg (1.75× mean)X2, KR: 0.868 mg per 40 mg (1.05× mean)X2, KRCG: 1.060 mg per 40 mg (1.04× mean)X2, QDG: 1.050 mg per 40 mg (1.12× mean)X2, QCG: 1.350 mg per 40 mg (1.08× mean)X2, Rutin: 1.171 mg per 40 mg (1.00× mean)X2, IR: 0.803 mg per 40 mg (1.03× mean)X2, Quercetin: 0.024 mg per 40 mg (0.42× mean)X3, 6-HKA: 0.050 mg per 40 mg (2.28× mean)X3, pHA: 0.025 mg per 40 mg (0.76× mean)X3, GA: 0.016 mg per 40 mg (1.35× mean)X3, PA: 0.367 mg per 40 mg (1.47× mean)X3, KR: 0.713 mg per 40 mg (0.87× mean)X3, KRCG: 1.005 mg per 40 mg (0.99× mean)X3, QDG: 0.712 mg per 40 mg (0.76× mean)X3, QCG: 1.407 mg per 40 mg (1.12× mean)X3, Rutin: 2.190 mg per 40 mg (1.87× mean)X3, IR: 0.730 mg per 40 mg (0.93× mean)X3, Quercetin: 0.019 mg per 40 mg (0.33× mean)X4, 6-HKA: 0.047 mg per 40 mg (2.15× mean)X4, pHA: 0.018 mg per 40 mg (0.55× mean)X4, GA: 0.015 mg per 40 mg (1.26× mean)X4, PA: 0.349 mg per 40 mg (1.39× mean)X4, KR: 0.704 mg per 40 mg (0.85× mean)X4, KRCG: 1.109 mg per 40 mg (1.09× mean)X4, QDG: 0.929 mg per 40 mg (0.99× mean)X4, QCG: 1.434 mg per 40 mg (1.14× mean)X4, Rutin: 1.066 mg per 40 mg (0.91× mean)X4, IR: 0.647 mg per 40 mg (0.83× mean)X4, Quercetin: 0.024 mg per 40 mg (0.42× mean)X5, 6-HKA: 0.039 mg per 40 mg (1.78× mean)X5, pHA: 0.020 mg per 40 mg (0.61× mean)X5, GA: 0.034 mg per 40 mg (2.86× mean)X5, PA: 0.651 mg per 40 mg (2.60× mean)X5, KR: 1.064 mg per 40 mg (1.29× mean)X5, KRCG: 1.614 mg per 40 mg (1.58× mean)X5, QDG: 1.204 mg per 40 mg (1.28× mean)X5, QCG: 2.104 mg per 40 mg (1.68× mean)X5, Rutin: 1.132 mg per 40 mg (0.97× mean)X5, IR: 1.018 mg per 40 mg (1.30× mean)X5, Quercetin: 0.025 mg per 40 mg (0.44× mean)X6, 6-HKA: 0.134 mg per 40 mg (6.12× mean)X6, pHA: 0.048 mg per 40 mg (1.46× mean)X6, GA: 0.031 mg per 40 mg (2.61× mean)X6, PA: 0.524 mg per 40 mg (2.09× mean)X6, KR: 1.116 mg per 40 mg (1.36× mean)X6, KRCG: 1.348 mg per 40 mg (1.32× mean)X6, QDG: 1.800 mg per 40 mg (1.91× mean)X6, QCG: 1.805 mg per 40 mg (1.44× mean)X6, Rutin: 1.507 mg per 40 mg (1.29× mean)X6, IR: 1.045 mg per 40 mg (1.34× mean)X6, Quercetin: 0.029 mg per 40 mg (0.51× mean)X7, 6-HKA: 0.056 mg per 40 mg (2.56× mean)X7, pHA: 0.028 mg per 40 mg (0.85× mean)X7, GA: 0.016 mg per 40 mg (1.35× mean)X7, PA: 0.425 mg per 40 mg (1.70× mean)X7, KR: 0.793 mg per 40 mg (0.96× mean)X7, KRCG: 1.031 mg per 40 mg (1.01× mean)X7, QDG: 1.042 mg per 40 mg (1.11× mean)X7, QCG: 1.357 mg per 40 mg (1.08× mean)X7, Rutin: 1.139 mg per 40 mg (0.97× mean)X7, IR: 0.766 mg per 40 mg (0.98× mean)X7, Quercetin: 0.021 mg per 40 mg (0.37× mean)Y1, 6-HKA: 0.002 mg per 40 mg (0.09× mean)Y1, pHA: 0.028 mg per 40 mg (0.85× mean)Y1, GA: not detectedY1, PA: 0.028 mg per 40 mg (0.11× mean)Y1, KR: 0.665 mg per 40 mg (0.81× mean)Y1, KRCG: 1.105 mg per 40 mg (1.08× mean)Y1, QDG: 1.090 mg per 40 mg (1.16× mean)Y1, QCG: 1.285 mg per 40 mg (1.03× mean)Y1, Rutin: 0.896 mg per 40 mg (0.76× mean)Y1, IR: 0.543 mg per 40 mg (0.69× mean)Y1, Quercetin: 0.048 mg per 40 mg (0.85× mean)Y2, 6-HKA: 0.003 mg per 40 mg (0.14× mean)Y2, pHA: 0.033 mg per 40 mg (1.00× mean)Y2, GA: not detectedY2, PA: 0.031 mg per 40 mg (0.12× mean)Y2, KR: 0.656 mg per 40 mg (0.80× mean)Y2, KRCG: 0.936 mg per 40 mg (0.92× mean)Y2, QDG: 0.753 mg per 40 mg (0.80× mean)Y2, QCG: 1.318 mg per 40 mg (1.05× mean)Y2, Rutin: 0.808 mg per 40 mg (0.69× mean)Y2, IR: 0.627 mg per 40 mg (0.80× mean)Y2, Quercetin: 0.074 mg per 40 mg (1.30× mean)Manufacturer≤ ¼½mean2×≥ 4×not detectedThe 51 batch profiles: each constituent relative to the 51-batch meanMeasured data from Liu et al. 2022, Table 2. Each cell is one constituent in one batch, shaded by its content relative to the mean of the 51 batches: warm (copper) shades below the mean, cool (steel) shades above, from a quarter or less to four times or more. Organic acids vary most: protocatechuic acid ranges from 0.008 to 1.132 mg per 40 mg extract. The six flavonol glycosides vary least, except in batch V2, where two coumaroyl glycosides and QDG are far below the mean. Free quercetin is highest in L2. Every value is in the data table below the figure.6-HKApHAGAPAKRKRCGQDGQCGRutinIRQuercetinABCDEFGHIJKLMNOPQRSTUVWXY≤ ¼½mean2×≥ 4×not detected
Measured data Liu et al. 2022, Table 2; shading computed from the published values (content divided by the mean of 51 batches, not-detected counted as zero in the mean, as in the authors' average row). Abbreviations are expanded in the data table.

What was measured

Material
51 batches of ginkgo extract tablets and capsules bought on the market in China, 1 to 7 batches from each of 25 manufacturers (A–Y); 13 manufacturers contributed one batch.
Method
UPLC with diode-array detection at 260 nm; 11 constituents quantified against reference standards; recovery 97.5–107% (Table 1 of the paper).
Units
mg per 40 mg of ginkgo extract, normalized to the labeled extract content of each product.
Fingerprint
Correlation of each chromatogram with the common pattern of the 51 batches (59 common peaks, ChemPattern 2.0).
Not measured
Terpene lactones, ginkgolic acids, compendial total flavonol glycosides and any biological activity.

Sampling limits to keep in mind

  • A market purchase in one country, not a random or representative sample. These are preparations sold in China, used here as a published example of batch variation, not as a description of U.S. products.
  • One laboratory and one method; no measurement uncertainty is reported for individual values.
  • The authors note that preparation makers can buy registered extract from other companies, so a manufacturer code does not identify the extract source.
  • The similarity reference is derived from the same 51 batches. The authors report that the Chinese Pharmacopoeia 2020 fingerprint, which focuses on flavonol glycosides, gave similarity above 0.9 for all samples (data not shown in the paper).
  • Table 3 of the paper lists 17 batches below 0.85. Table 2's values give 19 (U1 at 0.78 and X1 at 0.83 are missing from Table 3); this page uses Table 2.

Our reading of Table 2 Within manufacturer K, batches K3 and K4 contain 2.2 times the rutin of K1, K2 and K5, while the other five glycosides differ by at most 16%, a pattern that warrants investigation. Rutin is a cheap, widely available flavonol glycoside, and the authors name its illegal addition as a known concern.

The European Pharmacopoeia monograph “Ginkgo dry extract, refined and quantified” sets flavone glycosides at 22.0–27.0%, terpene lactones at 5.0–7.0% (ginkgolides A, B and C 2.8–3.4%, bilobalide 2.6–3.2%) and ginkgolic acids at no more than 5 ppm (EMA/HMPC/321095/2012). Those analytes were not measured here, so these batches cannot be judged against it. Next: apply a specification.

Every value: Table 2 of Liu et al. 2022, with three computed columns

Values in mg per 40 mg extract as printed; n.d. = not detected (“–” in the paper). The printed total was checked against the 11 columns for every batch; the column maxima and averages match the summary rows of Table 2. Decision column: all tests on, default specification (section 03).

Liu et al. 2022, Table 2: content of 11 constituents (mg per 40 mg extract) and fingerprint similarity of 51 ginkgo batches, with three computed columns
Batch6-HKApHAGAPAKRKRCGQDGQCGRutinIRQuercetinTotal (printed)SimilaritySix glycosides (computed)Rutin share (computed)Decision, all tests on (computed)
A10.0480.0330.0140.3650.8180.8201.0090.8862.0750.6440.0386.7491.006.25233%Rutin share
B10.0770.0510.0530.7150.8140.7861.0700.8852.1160.6320.1017.2980.936.30334%Rutin share
C10.0070.0160.0030.0700.9241.0401.0801.2402.1960.8440.0917.5110.897.32430%Specification
D10.0200.0250.0050.1410.7560.9470.6751.1940.7740.7510.0565.3430.905.09715%Held
E10.0100.037n.d.0.0900.7241.1930.9901.3110.7730.5630.0455.7360.865.55414%Held
F10.0220.0610.0650.9080.8310.9131.1171.1111.9640.7620.0237.7790.866.69829%Rutin share
F20.0070.0650.0490.9550.8971.0071.1881.2151.0710.8350.0277.3170.876.21317%Supplier
G10.0070.026n.d.0.2130.7910.6920.8860.8560.8050.7860.0185.0800.924.81617%Specification
G20.0060.035n.d.0.1830.8580.8150.8641.1350.8870.7960.0205.5980.865.35517%Accepted
G30.0080.031n.d.0.1870.8030.8030.8851.1190.8690.7410.0245.4710.865.22017%Accepted
G40.0040.037n.d.0.2150.8780.8931.0191.2040.9150.8180.0266.0090.915.72716%Accepted
H10.0070.026n.d.0.0680.7441.1011.1161.3840.8090.7040.0385.9970.865.85814%Held
I10.0570.0270.0190.4210.9600.9890.8921.2401.1440.8860.0226.6560.986.11119%Held
J10.0290.0740.0470.6920.9251.0421.2061.2920.8590.8330.0227.0200.936.15714%Held
K10.0180.032n.d.0.0560.5981.0260.8421.2270.6930.5070.0565.0550.754.89314%Specification
K20.0180.035n.d.0.0620.6271.0110.8311.2060.7000.5360.0525.0780.864.91114%Specification
K30.0200.0340.0090.0660.6120.9700.9081.1351.6360.5210.0525.9630.745.78228%Rutin share
K40.0190.034n.d.0.0320.6131.0030.9611.1731.6750.5260.0486.0860.735.95128%Rutin share
K50.0180.028n.d.0.0580.5971.0020.9321.1700.8330.5110.0785.2270.855.04517%Supplier
L10.0090.0790.0541.1320.8801.0261.1271.3010.8230.8350.0217.2880.835.99214%Fingerprint
L20.0050.030n.d.0.1000.4910.8980.6141.1210.5010.4920.2724.5230.714.11712%Specification
M10.0090.022n.d.0.1051.0111.3241.1521.5590.9730.9470.0487.1500.826.96614%Fingerprint
N10.0110.0250.0010.0550.7971.1051.0101.3080.7970.7260.0605.8950.845.74314%Fingerprint
N20.0140.027n.d.0.0670.8081.0710.8291.2400.7900.7350.0535.6340.875.47314%Supplier
O1n.d.0.009n.d.0.0080.7061.0980.3391.3730.8200.6180.0755.0460.784.95417%Specification
P10.0160.0340.0020.2001.1081.0341.0561.1241.2071.1820.0727.0350.886.71118%Held
Q10.0090.0390.0020.1420.8590.8750.6501.1120.8000.7170.0305.2330.905.01316%Supplier
Q20.0230.0380.0100.1950.7080.9320.9101.2441.8730.5930.0186.5450.926.26030%Rutin share
Q30.0040.0350.0050.1120.7730.8400.7351.1191.7250.6540.0426.0430.865.84630%Rutin share
R10.0020.023n.d.0.0390.6960.9820.8051.1600.6150.7010.1425.1670.834.95912%Specification
R20.0080.029n.d.0.0370.7521.0710.9431.2560.6690.7580.1485.6720.735.44912%Fingerprint
R30.0090.029n.d.0.0380.7611.0750.9251.2481.3580.7720.1556.3700.746.13922%Fingerprint
S10.0340.0500.0300.6971.2961.1600.9351.4042.9061.1850.0299.7270.968.88633%Specification
S20.0580.0450.0240.6691.3331.1351.1181.3621.2471.2320.0328.2550.937.42717%Specification
T10.0020.027n.d.0.0630.7001.0530.9041.2070.6300.7080.1515.4450.715.20212%Fingerprint
U10.0030.015n.d.0.0370.9351.2240.9041.4190.8730.8590.1276.3950.786.21414%Fingerprint
V10.0290.046n.d.0.0490.9131.4961.4401.7492.5070.7900.0829.1010.458.89528%Specification
V20.0150.0450.0520.0330.7830.0590.0860.3681.3141.8270.0414.6240.864.43730%Specification
V30.0050.023n.d.0.0220.8180.8960.7241.0700.9200.7590.0365.2720.845.18718%Fingerprint
W10.0040.012n.d.0.0180.9471.1150.9121.2620.8770.9060.0206.0710.786.01915%Fingerprint
W20.0030.013n.d.0.0180.9611.1350.9811.3191.0900.9230.0226.4650.866.40917%Supplier
W30.0120.0190.0110.0590.8071.0190.7341.1720.9150.8590.0955.7010.885.50617%Supplier
X10.0350.0320.0200.5540.8091.1231.1071.3630.8190.7560.0216.6380.835.97714%Fingerprint
X20.0640.0270.0190.4390.8681.0601.0501.3501.1710.8030.0246.8750.926.30219%Supplier
X30.0500.0250.0160.3670.7131.0050.7121.4072.1900.7300.0197.2340.956.75732%Rutin share
X40.0470.0180.0150.3490.7041.1090.9291.4341.0660.6470.0246.3410.855.88918%Supplier
X50.0390.0200.0340.6511.0641.6141.2042.1041.1321.0180.0258.9050.938.13614%Specification
X60.1340.0480.0310.5241.1161.3481.8001.8051.5071.0450.0299.3840.958.62117%Specification
X70.0560.0280.0160.4250.7931.0311.0421.3571.1390.7660.0216.6730.956.12819%Supplier
Y10.0020.028n.d.0.0280.6651.1051.0901.2850.8960.5430.0485.6900.735.58416%Fingerprint
Y20.0030.033n.d.0.0310.6560.9360.7531.3180.8080.6270.0745.2370.535.09816%Fingerprint

03 · Apply a specification

Each added test removes batches that the assay accepted

Start with the targeted assay alone, then add a free-aglycone limit, a profile ratio, the fingerprint and supplier qualification. Every decision is computed live from the published values.

Shown at the default settings: six-glycoside sum 5.0–7.0 mg per 40 mg, targeted assay only, 80 mg extract per serving. The table below the tool gives the result as each test is added.

Accepted
38 of 51
Held
0
Rejected
13
Six-glycoside sum delivered, accepted batches
10.0–13.9 mg per serving (1.4-fold)
Protocatechuic acid delivered (not specified)
0.036–2.26 mg per serving (63-fold)

Decision for each batch, grouped by manufacturer (A–Y)

    • A1: Accepted; six-glycoside sum 6.252 mg per 40 mg, similarity 1.00
    • B1: Accepted; six-glycoside sum 6.303 mg per 40 mg, similarity 0.93
    • C1: Outside the marker specification; six-glycoside sum 7.324 mg per 40 mg, similarity 0.89
    • D1: Accepted; six-glycoside sum 5.097 mg per 40 mg, similarity 0.90
    • E1: Accepted; six-glycoside sum 5.554 mg per 40 mg, similarity 0.86
    • F1: Accepted; six-glycoside sum 6.698 mg per 40 mg, similarity 0.86
    • F2: Accepted; six-glycoside sum 6.213 mg per 40 mg, similarity 0.87
    • G1: Outside the marker specification; six-glycoside sum 4.816 mg per 40 mg, similarity 0.92
    • G2: Accepted; six-glycoside sum 5.355 mg per 40 mg, similarity 0.86
    • G3: Accepted; six-glycoside sum 5.220 mg per 40 mg, similarity 0.86
    • G4: Accepted; six-glycoside sum 5.727 mg per 40 mg, similarity 0.91
    • H1: Accepted; six-glycoside sum 5.858 mg per 40 mg, similarity 0.86
    • I1: Accepted; six-glycoside sum 6.111 mg per 40 mg, similarity 0.98
    • J1: Accepted; six-glycoside sum 6.157 mg per 40 mg, similarity 0.93
    • K1: Outside the marker specification; six-glycoside sum 4.893 mg per 40 mg, similarity 0.75
    • K2: Outside the marker specification; six-glycoside sum 4.911 mg per 40 mg, similarity 0.86
    • K3: Accepted; six-glycoside sum 5.782 mg per 40 mg, similarity 0.74
    • K4: Accepted; six-glycoside sum 5.951 mg per 40 mg, similarity 0.73
    • K5: Accepted; six-glycoside sum 5.045 mg per 40 mg, similarity 0.85
    • L1: Accepted; six-glycoside sum 5.992 mg per 40 mg, similarity 0.83
    • L2: Outside the marker specification; six-glycoside sum 4.117 mg per 40 mg, similarity 0.71
    • M1: Accepted; six-glycoside sum 6.966 mg per 40 mg, similarity 0.82
    • N1: Accepted; six-glycoside sum 5.743 mg per 40 mg, similarity 0.84
    • N2: Accepted; six-glycoside sum 5.473 mg per 40 mg, similarity 0.87
    • O1: Outside the marker specification; six-glycoside sum 4.954 mg per 40 mg, similarity 0.78
    • P1: Accepted; six-glycoside sum 6.711 mg per 40 mg, similarity 0.88
    • Q1: Accepted; six-glycoside sum 5.013 mg per 40 mg, similarity 0.90
    • Q2: Accepted; six-glycoside sum 6.260 mg per 40 mg, similarity 0.92
    • Q3: Accepted; six-glycoside sum 5.846 mg per 40 mg, similarity 0.86
    • R1: Outside the marker specification; six-glycoside sum 4.959 mg per 40 mg, similarity 0.83
    • R2: Accepted; six-glycoside sum 5.449 mg per 40 mg, similarity 0.73
    • R3: Accepted; six-glycoside sum 6.139 mg per 40 mg, similarity 0.74
    • S1: Outside the marker specification; six-glycoside sum 8.886 mg per 40 mg, similarity 0.96
    • S2: Outside the marker specification; six-glycoside sum 7.427 mg per 40 mg, similarity 0.93
    • T1: Accepted; six-glycoside sum 5.202 mg per 40 mg, similarity 0.71
    • U1: Accepted; six-glycoside sum 6.214 mg per 40 mg, similarity 0.78
    • V1: Outside the marker specification; six-glycoside sum 8.895 mg per 40 mg, similarity 0.45
    • V2: Outside the marker specification; six-glycoside sum 4.437 mg per 40 mg, similarity 0.86
    • V3: Accepted; six-glycoside sum 5.187 mg per 40 mg, similarity 0.84
    • W1: Accepted; six-glycoside sum 6.019 mg per 40 mg, similarity 0.78
    • W2: Accepted; six-glycoside sum 6.409 mg per 40 mg, similarity 0.86
    • W3: Accepted; six-glycoside sum 5.506 mg per 40 mg, similarity 0.88
    • X1: Accepted; six-glycoside sum 5.977 mg per 40 mg, similarity 0.83
    • X2: Accepted; six-glycoside sum 6.302 mg per 40 mg, similarity 0.92
    • X3: Accepted; six-glycoside sum 6.757 mg per 40 mg, similarity 0.95
    • X4: Accepted; six-glycoside sum 5.889 mg per 40 mg, similarity 0.85
    • X5: Outside the marker specification; six-glycoside sum 8.136 mg per 40 mg, similarity 0.93
    • X6: Outside the marker specification; six-glycoside sum 8.621 mg per 40 mg, similarity 0.95
    • X7: Accepted; six-glycoside sum 6.128 mg per 40 mg, similarity 0.95
    • Y1: Accepted; six-glycoside sum 5.584 mg per 40 mg, similarity 0.73
    • Y2: Accepted; six-glycoside sum 5.098 mg per 40 mg, similarity 0.53
  • Accepted
  • Outside the marker specification
  • Free quercetin above 0.2 mg per 40 mg extract
  • Rutin above 25% of the six glycosides
  • Fingerprint similarity below the threshold
  • Supplier not qualified: another of its batches failed a check
  • Held: only one batch on record, so the supplier cannot be qualified

What a serving delivers

Each dot is one batch. Values: Liu et al. 2022, Table 2, scaled to the serving.

Six-glycoside sum, mg per servingAll 51 batches, as purchasedAccepted, as purchased05101520Serving: 80 mg extract (hypothetical label). Shaded: the specification.Protocatechuic acid, mg per servingAccepted, as purchased0.010.1110Log scale. No limit set: the specification does not cover it.Six-glycoside sum, mg per servingAll 51 batches, as purchasedAccepted, as purchased05101520Serving: 80 mg extract (hypothetical label).Shaded: the specification.Protocatechuic acid, mg per servingAccepted, as purchased0.010.1110Log scale. No limit set:the specification does not cover it.

Measured data Hypothetical example Values: Liu et al. 2022, Table 2. Specification, ratio limit, supplier rule and serving are hypothetical; the 0.2 mg quercetin limit and the 0.85 similarity cut are as stated by the authors.

Batches accepted as tests are added in order (hypothetical specification 5.0–7.0 mg six-glycoside sum per 40 mg extract; serving 80 mg extract)

Tests appliedAcceptedHeldRejectedSix glycosides per serving, accepted (mg)Protocatechuic acid per serving, accepted (mg)
Targeted assay against the specification3801310.0–13.90.036–2.264
+ free-quercetin limit3801310.0–13.90.036–2.264
+ profile ratio (rutin share)3002110.0–13.90.036–2.264
+ fingerprint similarity ≥ 0.851803310.0–13.40.036–1.910
+ supplier qualification364210.4–11.50.366–0.430

At the default specification the assay accepts 38 batches. The rutin ratio removes 8, the fingerprint 12 more, and supplier qualification leaves 3, all from manufacturer G, with 6 more held for lack of history.

Method, assumptions and limits

What it calculates. For each batch, the first enabled test it fails, in this order: marker specification (S), free quercetin (Q), rutin share (R), fingerprint similarity (F); then, if supplier qualification is on, U for a batch whose manufacturer has any batch failing Q, R or F, and H (held) for a manufacturer with a single batch.

Equations. Six-glycoside sum = KR + KRCG + QDG + QCG + rutin + IR (mg per 40 mg extract). Rutin share = rutin ÷ six-glycoside sum. Dose per serving = content × serving ÷ 40 mg. Standardized fill = serving × (lower + upper limit) ÷ 2 ÷ marker content, in mg extract; any other constituent then delivers its content ÷ 40 × fill.

Assumptions. Values are used as printed, without measurement uncertainty; a not-detected value counts as zero, as in the authors' totals. Limits are inclusive. The serving and the standardization are arithmetic on a hypothetical label, not dosing advice and not a formulation.

Valid range. Limits from 0 to 20 mg per 40 mg; a lower limit above the upper limit is swapped and the page says so.

What it does not establish. Authenticity, safety or activity of any product. A failed check marks a batch for investigation; it does not prove adulteration. The 25% rutin limit was placed at a gap in these same data, which a real specification must not do: it would be set from authenticated reference lots.

Verification. The default results were checked against an independent calculation and against the totals, maxima and averages printed in Table 2.

04 · What a serving delivers

A fixed serving of extract delivers a variable dose

At a hypothetical label of 80 mg extract per serving, the same labeled amount delivers different amounts of each constituent. A specification narrows the constituent it names and leaves the rest as they come.

2.2-fold

Six-glycoside dose across all 51 batches

8.2 to 17.8 mg per 80 mg serving, from the same labeled extract amount.

141-fold

Protocatechuic acid across all 51

0.016 to 2.26 mg per serving. No specification in this demonstration covers it.

1.4-fold

Six-glycoside dose inside the specification

10.0 to 13.9 mg per serving in the 38 accepted batches: a 5.0–7.0 range allows up to 1.4-fold by design.

1.2-fold

Protocatechuic acid after every test

0.37 to 0.43 mg per serving in the 3 batches still accepted, all from one manufacturer.

These are batch-to-batch differences. Unit-to-unit uniformity within one batch is a separate test that needs per-unit data, which the study does not report. Hypothetical example

Computed from Liu et al. 2022, Table 2, for a hypothetical 80 mg serving; change the serving in section 03.

05 · Process correction

Blending corrects a marker, and it can also hide a failed batch

Mixing lots by mass is linear, so a blend's content of each measured constituent can be computed from published values. A fingerprint similarity cannot be computed this way; it would have to be measured on the blend.

Correcting strength

S2 is above and G1 below the hypothetical range, and both pass every authenticity check. A blend of about 45% S2 and 55% G1 gives 6.0 mg.

Correcting strength: two batches that pass every authenticity check, one above and one below the specification, blended to 6.0 mg (values per 40 mg extract)

QuantityS2 (measured)G1 (measured)Blend 45% S2 + 55% G1 (computed)
Six glycosides7.427 mg4.816 mg6.000 mg
Free quercetin0.032 mg0.018 mg0.024 mg
Protocatechuic acid0.669 mg0.213 mg0.420 mg
Rutin share of six glycosides17%17%17%
Fingerprint similarity0.930.92not computable

Hiding a failure

L2 exceeds the free-quercetin limit and has the lowest glycoside content. Mixed 1:1 with X6, the blend passes both the marker range and the limit while half of it is the failed batch.

Hiding a failure: a batch over the free-quercetin limit, blended 1:1 with a rich batch (values per 40 mg extract)

QuantityL2 (measured)X6 (measured)Blend 50% L2 + 50% X6 (computed)
Six glycosides4.117 mg8.621 mg6.369 mg
Free quercetin0.272 mg0.029 mg0.151 mg
Protocatechuic acid0.100 mg0.524 mg0.312 mg
Rutin share of six glycosides12%17%16%
Fingerprint similarity0.710.95not computable

Measured data Hypothetical example Batch values: Liu et al. 2022, Table 2. Blends are computed by mass balance, not measured lots; not-detected values count as zero.

Standardizing the serving fixes one number

With every batch-level test on and the fill per serving adjusted so each of the 18 accepted batches delivers 12.0 mg of the six glycosides, the extract per serving ranges from 72 to 96 mg. Protocatechuic acid still ranges from 0.034 to 1.84 mg per serving, 55-fold, against 53-fold before the adjustment.

Under Part 111, a component that fails its identity specification must be rejected and not used (21 CFR 111.77(b)). Other specification failures may be corrected only by a treatment, in-process adjustment or reprocessing that quality control approves after a material review (111.77(a), 111.90). EUTECNIQ proposes to write the fingerprint and authenticity checks into identity and to blend only lots that pass them. Proposed capability

eCFR 21 CFR 111.77 and 111.90 (version of October 28, 2026). Whether a fingerprint failure is an identity failure depends on how the manufacturer writes its identity specification under 111.70(b)(1).

06 · What each test catches here

No single test sorted these batches correctly on its own

Run on the 51 published batches at the default settings, each test removes a different set, and two kinds of evidence a full decision needs are not in the dataset at all.

TestWhat it measuresWhat it cannot tellIn these 51 batches
Targeted assay, six-glycoside sumSix named glycosides against reference standardsAnything not among the six; whether rutin was added13 outside 5.0–7.0 mg; 38 accepted
Free-quercetin limitFree aglycone, a marker of hydrolysis or added aglyconeAdded glycosides such as rutinOne batch above 0.2 mg (L2, 0.272), already outside the range
Profile ratio, rutin shareWhether one glycoside is out of proportion to the othersIts own limit, without authenticated reference lots12 batches above 25%, including A1 at similarity 1.00
Fingerprint similarityThe whole UPLC pattern against the market's common patternWhether the reference itself is authentic19 below 0.85; 14 of them inside the marker range
Supplier qualificationWhether a source's batches pass consistently over timeAnything about a source with one batch on recordOnly G, of 12 multi-batch manufacturers, has no batch failing an authenticity check
Non-targeted LC-HRMS screeningCompounds nobody specified, by accurate massQuantity without standards; identity without confirmationNot performed in this study
Bioassay or clinical evidenceWhat the material doesChemical identityNot performed in this study

Counts computed from Liu et al. 2022, Table 2. For non-targeted screening and confidence levels see targeted and non-targeted analysis; for a case where only isotope ratios separated synthetic from natural curcuminoids see discovery and characterization; for decision rules near a limit see certificate-of-analysis science.

07 · What EUTECNIQ proposes

Connect sourcing, specification, process and records in one decision

A contract testing laboratory reports results against the methods and limits its client sends. Every outcome on this page turned on choices made before a test ran: which limits, which supplier, which blending rule. EUTECNIQ proposes to make those choices with its clients and keep the reasons on record.

01 Sourcing

Qualify the extract source

Qualify the plant material and the extraction process behind an ingredient, since a brand or manufacturer code need not identify it. Keep authenticated reference lots of documented origin.

02 Specification

Set limits from many lots

Combine a marker range, an aglycone limit, profile ratios and a fingerprint compared with authenticated references, each limit justified from multi-lot data and documented.

03 Process

Correct strength only in lots that pass identity

Write blending and standardization rules in advance, apply them only to lots that pass identity and authenticity, and state which constituents the correction leaves variable.

04 Records

One record per lot

Link the supplier's certificate, its periodic confirmation (21 CFR 111.75(a)(2)(ii)), every test result, the decision and its reason, and the dose a serving delivers.

Proposed capabilityEUTECNIQ has not built or operated this system. The roles above describe what it proposes to offer.

08 · Sources

Sources for this demonstration

Consistency demonstration: dataset, markers and specifications

  1. Liu L-n, Jin H-y, Ke Z, Xu W-y, Sun L, Ma S-c. A strategy for quality control of ginkgo biloba preparations based on UPLC fingerprint analysis and multi-component separation combined with quantitative analysis. Chin Med. 2022;17:72. Open access, CC BY 4.0 (PMC9202209). Table 2 values (51 batches, 11 constituents, similarity) used throughout this page; full text read November 1, 2026. doi.org/10.1186/s13020-022-00618-3
  2. European Medicines Agency, Committee on Herbal Medicinal Products. Assessment report on Ginkgo biloba L., folium. EMA/HMPC/321095/2012, final, January 28, 2014 (herbal preparations: Ph. Eur. monograph 1827, Ginkgo dry extract, refined and quantified, p. 4). Read November 1, 2026. ema.europa.eu/en/documents/herbal-report/final-assessment-report-ginkgo-biloba-l-folium_en.pdf
  3. EMA Committee on Herbal Medicinal Products. Reflection paper on markers used for quantitative and qualitative analysis of herbal medicinal products and traditional herbal medicinal products. EMEA/HMPC/253629/2007, July 15, 2008 (definitions of active and analytical markers). Read November 1, 2026. ema.europa.eu/en/documents/scientific-guideline/reflection-paper-markers-used-quantitative-qualitative-analysis-herbal-medicinal-products_en.pdf

Consistency demonstration: U.S. dietary supplement CGMP (21 CFR Part 111)

  1. Electronic Code of Federal Regulations. 21 CFR 111.70, What specifications must you establish? (paragraphs (b) and (e)). eCFR version of October 28, 2026, read November 1, 2026. ecfr.gov/current/title-21/chapter-I/subchapter-B/part-111/subpart-E/section-111.70
  2. Electronic Code of Federal Regulations. 21 CFR 111.75, What must you do to determine whether specifications are met? (paragraph (a): identity testing; reliance on a qualified supplier's certificate of analysis). eCFR version of October 28, 2026, read November 1, 2026. ecfr.gov/current/title-21/chapter-I/subchapter-B/part-111/subpart-E/section-111.75
  3. Electronic Code of Federal Regulations. 21 CFR 111.77, What must you do if established specifications are not met? eCFR version of October 28, 2026, read November 1, 2026. ecfr.gov/current/title-21/chapter-I/subchapter-B/part-111/subpart-E/section-111.77
  4. Electronic Code of Federal Regulations. 21 CFR 111.90, What requirements apply to treatments, in-process adjustments, and reprocessing? eCFR version of October 28, 2026, read November 1, 2026. ecfr.gov/current/title-21/chapter-I/subchapter-B/part-111/subpart-E/section-111.90

Health information notice. These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease, and nothing here is medical advice.

Read the full notice

The information is for general education only. It does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed. Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.

EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.

Ready to start a development project?

Tell us about an ingredient you want to specify, verify or license. Questions? Email [email protected]